UC Department of Internal Medicine Honors Trainees' Research
Keith Saum won second place in the basic science category for the Trainees Research Grand Rounds Poster Session as part of the 6th Annual Department of Internal Medicine Research Symposium. Gregory Rouan, MD, is also shown.
Sulsal Hague, MD, won second place the clinical research category for the Trainees Research Grand Rounds Poster Session as part of the 6th Annual Department of Internal Medicine Research Symposium. Gregory Rouan, MD, is also shown.
Steven Houser, PhD, president of the American Heart Association, and professor and senior associate dean at Temple University, presented the keynote address at the Saturday session of the 6th Annual Department of Internal Medicine Research Symposium.
Bruce Sullenger, PhD, Joseph W. and Dorothy W. Beard Professor of Experimental Surgery, Department of Surgery, Duke University Medical Center, spoke at the 6th Annual Department of Internal Medicine Research Symposium.
Richa Patel, MD, received honorable mention in the clinical research category for the Trainees Research Grand Rounds Poster Session as part of the 6th Annual Department of Internal Medicine Research Symposium. She is shown with Gregory Rouan, MD.
Tags
Related Stories
Why can it get so hot at times?
September 3, 2026
Cincinnati is experiencing more days of extreme heat this summer than in previous decades, due in large part to warmer global temperatures. But explanations for these higher temperatures also relate to regional factors, including the city's location in a river valley and large proportion of built environment.
Cancer Center plays key role in lab research, clinical trials for new pancreatic cancer drug
September 1, 2026
WLWT and WCPO highlighted the contributions of University of Cincinnati Cancer Center researchers that helped lead to the recent FDA approval of daraxonrasib, a new treatment for pancreatic cancer.
Cancer Center physician receives $150,000 New Investigator Research Grant to study treatment-resistant leukemia
September 1, 2026
The University of Cincinnati Cancer Center’s Sarah Skuli, MD, PhD, received a two‑year, $150,000 Leukemia Research Foundation New Investigator Grant to study TP53‑mutated leukemia, a treatment‑resistant subtype with very poor outcomes.